MoneyWorks4Me

Marksans Pharma - Quaterly Results

30 May 2023 Evaluate
A decrease in the sales to Rs. 1530.45 millions was observed for the quarter ended March 2023. The sales stood at Rs. 1762.78 millions during the similar quarter previous year.Net profit declined -16.88% to Rs. 178.10 millions from Rs. 214.27 millions.Operating profit for the quarter ended March 2023 decreased to 270.12 millions as compared to 345.16 millions of corresponding quarter ended March 2022.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202303 202203 % Var 202303 202203 % Var 202303 202203 % Var
Sales 1530.45 1762.78 -13.18 6552.04 6582.89 -0.47 6552.04 6582.89 -0.47
Other Income 43.03 76.48 -43.74 604.82 422.51 43.15 604.82 422.51 43.15
PBIDT 270.12 345.16 -21.74 1523.85 1559.66 -2.30 1523.85 1559.66 -2.30
Interest 6.58 12.78 -48.51 36.13 37.95 -4.80 36.13 37.95 -4.80
PBDT 263.54 332.38 -20.71 1487.72 1521.71 -2.23 1487.72 1521.71 -2.23
Depreciation 35.09 46.08 -23.85 167.37 176.63 -5.24 167.37 176.63 -5.24
PBT 228.45 286.30 -20.21 1320.35 1345.08 -1.84 1320.35 1345.08 -1.84
TAX 50.35 72.03 -30.10 291.69 305.20 -4.43 291.69 305.20 -4.43
Deferred Tax -4.21 -11.26 -62.61 -1.71 5.04 -133.93 -1.71 5.04 -133.93
PAT 178.10 214.27 -16.88 1028.66 1039.88 -1.08 1028.66 1039.88 -1.08
Equity 453.16 409.31 10.71 453.16 409.31 10.71 453.16 409.31 10.71
PBIDTM(%) 17.65 19.58 -9.86 23.26 23.69 -1.84 23.26 23.69 -1.84
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..